TriNetX Announces the Appointment of Shogo Wakabayashi as Japan Country Manager
PR94173
CAMBRIDGE, Mass., Jan. 27, 2022 /PRNewswire=KYODO JBN/--
TriNetX, the global network of healthcare organizations driving real-world
research to accelerate the development of new therapies, has announced that
Shogo Wakabayashi has joined the company as Country Manager for Japan.
Wakabayashi, a business leader with extensive global experience bringing new
offerings to market, will be focused on expanding the TriNetX network among
healthcare organizations in Japan.
Photo - https://mma.prnewswire.com/media/1730654/Shogo_Wakabayashi.jpg
Logo - https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg
"Shogo's global experience and innovative spirit greatly enhances the TriNetX
team and establishes leadership for us in Japan," said Steve Lethbridge, Senior
Vice President, Global Healthcare Partnerships. "His entrepreneurial drive and
success in launching new business initiatives is exactly what we need to
deliver the value of the TriNetX network to healthcare organizations in the
country."
Wakabayashi has succeeded in senior-level positions with Philips Japan and with
a Japanese IoT startup. As the Senior Program Manager for Connected Care
Informatics with Philips, he led the company's launch of its EHR business in
Japan, as the first foreign EHR to enter the world's second largest EHR market.
He also successfully delivered multiple new businesses in Online-Merge-Offline
(OMO) commerce as a hands-on consultant at Nomura Research Institute.
"I'm thrilled to be a part of the TriNetX organization and pleased to
contribute to the global expansion of the TriNetX ecosystem," said Wakabayashi.
"Japan is third only to the U.S. and China in the pharmaceutical market and
growing the network of healthcare organizations is critical for supporting
research activities in the country."
TriNetX is the largest and fastest growing collaborative research platform with
healthcare organizations and life sciences companies spanning North and South
America, EMEA, and Asia-Pacific. The company offers a unique opportunity for
healthcare organizations to join its network and take advantage of up-to-date,
global real-world data (RWD) for investigator initiated and industry-sponsored
research opportunities.
"TriNetX has experienced tremendous growth, and as more healthcare
organizations join the network, the greater all members benefit especially in
terms of the ability to conduct collaborative research with peer institutions
both within Japan and across the world," Wakabayashi continued. "Investigators
leverage the power of the TriNetX platform to better understand patient
populations, and that power ultimately unlocks opportunities to publish in
prestigious peer-reviewed journals, and engage with life sciences companies for
sponsored clinical trial and chart review opportunities."
Wakabayashi will be presenting a webinar for Japanese healthcare organizations
titled, The Benefits of Global Clinical Research and Trial Network Leveraging
Large-Scale Real-World Data on February 9, 2022 at 6:00 PM JST. To register,
please visit: https://bit.ly/TriNetX-Japan
About TriNetX, LLC
TriNetX is a global network of healthcare organizations and life sciences
companies driving real-world research to accelerate the development of new
therapies. Through its self-service, HIPAA, GDPR, and LGPD-compliant platform
of federated EHR, datasets, and consulting partnerships, TriNetX puts the power
of real-world data into the hands of its worldwide community to improve
protocol design, streamline trial operations, refine safety signals, and enrich
real-world evidence generation. For more information, visit: TriNetX at
www.trinetx.com or follow @TriNetX on Twitter.
Media Contact: TriNetX
Bill Stetson
+1-(857)-285-6038
press@trinetx.com
SOURCE: TriNetX
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。